首页 | 官方网站   微博 | 高级检索  
     


Fasting inhibits hepatic stellate cells activation and potentiates anti‐cancer activity of Sorafenib in hepatocellular cancer cells
Authors:Oriana Lo Re  Concetta Panebianco  Stefania Porto  Carlo Cervi  Francesca Rappa  Stefano Di Biase  Michele Caraglia  Valerio Pazienza  Manlio Vinciguerra
Affiliation:1. Center for Translational Medicine (CTM), International Clinical Research Center (ICRC), St. Anne's University Hospital, Brno, Czech Republic;2. Department of Biology, Masaryk University, Brno, Czech Republic;3. Gastroenterology Unit, IRCCS “Casa Sollievo della Sofferenza” Hospital, San Giovanni Rotondo, Italy;4. Department of Biochemistry, Biophysics and General Pathology, University of Campania Luigi Vanvitelli, Naples, Italy;5. Institute for Liver and Digestive Health, University College London (UCL), Royal Free Hospital, London, UK;6. Department of Experimental Biomedicine and Clinical Neurosciences, Section of Human Anatomy, University of Palermo, Palermo, Italy;7. Euro‐Mediterranean Institute of Science and Technology (IEMEST), Palermo, Italy;8. Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles (UCLA), California;9. Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania;10. Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy
Abstract:
Keywords:fasting  hepatic stellate cells  hepatocellular carcinoma  Sorafenib
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号